Show results for
Refine by
Biobank Articles & Analysis
16 news found
ACE program participation is offered exclusively to academic institutions and provides access to the POAI proprietary active ML/AI and biobank of primary patient dissociated tumor cells (DTCs) at no-cost, with data and IP protection provided to participants. ...
Key presentations on Bayer research to be presented at AACR 2023 are listed below: Oral presentation: BAY 2965501: A highly selective DGKzeta inhibitor for cancer immuno-therapy with first-in-class potential Abstract ND04, Session DDT001 – New Drugs on the Horizon: Part 1 Sunday, April 16, 2:05 PM – 2:20 PM (EDT), Tangerine Ballroom 2 (WF2) - Convention Center Poster ...
ByBayer AG
“These additional resources will support our recently launched commercial services which, for the first time, will provide the pharmaceutical and biobanking industries with access to our proprietary metabolic database, as well as to our advanced interpretive software to assist in various phases of drug research, development, and manufacturing,” said Dr. ...
” FEATURED PRESENTATIONS Using Genomic Data to Drive Precision Medicine Insights Wednesday, Oct. 26, 2022; 12:30 pm – 1:30 pm (lunch provided) Room 306, Convention Center South Building Partnering with DNAnexus to Unlock Myriad’s Precise™ Treatment Registry Kevin Haas, PhD, Chief Technology Officer, Myriad Genetics The City of Hope POSEIDON Platform: Driving Cancer ...
(“Valo”), the technology company focused on transforming the drug discovery and development process using human-centric data and artificial intelligence, announced today a first-of-its-kind multiyear collaboration in which Valo and Maccabi KSM Research and ...
Lifespin GmbH, based in Regensburg (Germany), with offices in Boston, Massachusetts, announced today that it has launched a new commercial service for the pharmaceutical and biobanking industry to assist companies in key phases of research, development, and manufacturing. ...
The Company’s platform includes epidemiologic, phenotypic, and genetic data that reflects a global population, as well as a biobank of patients’ blood samples and cell cultures. CENTOGENE believes this represents the only platform focused on comprehensive analysis of multi-level data to improve the understanding of rare hereditary diseases. ...
CHA Medical & Bio Group officially began construction of its Cell Gene Biobank (CGB) facility in Pangyo, South Korea. Investing over $250 million in the project, the new 710,000 ft2 site will comprise one of the world’s largest single facilities for cell and gene therapy manufacturing and advanced stem cell biobanking. ...
The City of Melbourne would like to thank and acknowledge valued partners for their support of the Melbourne Awards. 2021 Melbourne Award finalists: Aboriginal Melbourne – Kommargee Ketherba Radio 3KND - Melbourne’s first Aboriginal owned and managed AM radio station The Torch – program supporting Aboriginal art in prison and in the community Barpirdhila Foundation - ...
AMICA improves as it grows, enabling Immunai to unlock insights currently trapped in partners’ biobanks. Immunai will also extend its functional genomics capabilities to reprogram immune cells and validate targets to better support discovery, prioritization, and development of new therapies and drug combinations. ...
ByImmunai
Thus, Curator provides an opportunity for clinical investigators, patient organisations, registries, biobanks, and other institutions to showcase the scope of data that could be used for research without compromising the privacy of patients and data protection regulations. ...
Longenesis joins the 500 Startups family in a 16-week Singapore-based program designed to accelerate the growth of the best-selected startups through deep market insights, hands-on coaching and exposure to 500’s network of partners, experts, and talent. For the next 4 months, our team will be fully immersed in the Singapore market leveraging the 500 Startups’ network to multiply the ...
Morten Isaksen, CEO of Bio-Me, Christian Jonasson from The HUNT Study BioBank and Dr. Warren Flood, COO of Bio-Me. Dr. Carl Christian Gilhuus Moe, Chairman of Norway Healthtech and Trond Riiber Knudsen of TRK Group will jointly officiate the opening of Bio-Me’s lab facility. ...
ByBio-Me
Prior to commercial availability, the Axiom Microbiome Array was included in a pilot to determine a sample collection protocol for potential use in a wider UK Biobank participant collection program. "Axiom Microbiome Array provided useful data on samples that were collected as part of the pilot," said Dr. Rachael Almond, laboratory scientific director, UK ...
ARMADA is a first-of-its kind centralized biobank that will enable healthcare experts around the globe to identify infectious bacteria and track their repeat occurrences to specific sources while also sharing real-time solutions to life-threatening infections. ? ...
The Company provides best of breed cold storage equipment, centrifuges and rotors, consumables, liquid handling tools such as automated pipettes and market-leading informatics software for the biobanking industry. Its Fisher BioServices business offers end-to-end outsourced service solutions for biorepositories and biobanks. ...